RAYMOND JAMES & ASSOCIATES - INARI MED INC ownership

INARI MED INC's ticker is NARI and the CUSIP is 45332Y109. A total of 242 filers reported holding INARI MED INC in Q3 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of INARI MED INC
ValueSharesWeighting
Q4 2022$238,477
-24.3%
3,752
-13.4%
0.00%
Q3 2022$315,000
+5.0%
4,335
-1.9%
0.00%
Q2 2022$300,000
-24.6%
4,418
+0.7%
0.00%
Q1 2022$398,000
+1.3%
4,386
+1.8%
0.00%
Q4 2021$393,000
-41.3%
4,310
-47.9%
0.00%
-100.0%
Q3 2021$670,000
-60.8%
8,266
-54.9%
0.00%
-50.0%
Q2 2021$1,709,000
-20.3%
18,322
-8.6%
0.00%0.0%
Q1 2021$2,144,000
+190.5%
20,037
+137.1%
0.00%
+100.0%
Q4 2020$738,0008,4500.00%
Other shareholders
INARI MED INC shareholders Q3 2022
NameSharesValueWeighting ↓
Affinity Asset Advisors, LLC 125,000$11,409,0004.14%
SECTORAL ASSET MANAGEMENT INC 163,550$14,927,0002.25%
Lisanti Capital Growth, LLC 81,460$7,435,0001.08%
Pier Capital, LLC 99,422$9,074,0000.96%
Beck Bode, LLC 33,384$3,047,0000.76%
Nicholas Investment Partners, LP 104,932$9,577,0000.61%
CNA FINANCIAL CORP 24,773$2,261,0000.59%
NEXT CENTURY GROWTH INVESTORS LLC 56,523$5,158,0000.46%
HARBOURVEST PARTNERS LLC 38,540$3,518,0000.45%
Birchview Capital, LP 7,000$639,0000.41%
View complete list of INARI MED INC shareholders